Prevention of aromatase inhibitor-induced bone loss with alendronate in postmenopausal women: The BATMAN Trial
about
Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG'First, do no harm': managing the metabolic impacts of androgen deprivation in men with advanced prostate cancer.Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor-positive breast cancer: NCIC CTG MA.27.
P2860
Prevention of aromatase inhibitor-induced bone loss with alendronate in postmenopausal women: The BATMAN Trial
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Prevention of aromatase inhibi ...... pausal women: The BATMAN Trial
@ast
Prevention of aromatase inhibi ...... pausal women: The BATMAN Trial
@en
type
label
Prevention of aromatase inhibi ...... pausal women: The BATMAN Trial
@ast
Prevention of aromatase inhibi ...... pausal women: The BATMAN Trial
@en
prefLabel
Prevention of aromatase inhibi ...... pausal women: The BATMAN Trial
@ast
Prevention of aromatase inhibi ...... pausal women: The BATMAN Trial
@en
P2093
P2860
P1476
Prevention of aromatase inhibi ...... pausal women: The BATMAN Trial
@en
P2093
Adam Broad
Anna J Lomax
Ehtesham Abdi
Elaine G Yeow
Karen White
Nicholas Pocock
Philip Sambrook
Richard Bell
Sanjeev Sewak
P2860
P304
P356
10.1016/J.JBO.2013.08.001
P577
2013-08-15T00:00:00Z